11 января, 19:01

JV set up to treat lymphoma in China

Fosun Pharma will set up a joint venture with Nasdaq-listed Kite Pharma to develop and commercialize T-cell immunotherapy-based cancer treatment in China, the company said yesterday.

11 января, 02:17

Kite Pharma Inks Deals for CAR T Cell Drug in Japan, China

Kite Pharma (KITE) announced that it has entered into a strategic partnership with Daiichi Sankyo to develop and commercialize axicabtagene ciloleucel (KTE-C19) in Japan.

10 января, 17:27

4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal

Takeda to Buy ARIAD, More M&As to Follow in Biotech Sector?